Global Health (ASX: GLH) is an Australian-listed company in the Healthcare sector with a market capitalisation of $3.1M and the 1763rd-largest security on the ASX by market capitalisation. The GLH share price is $0.053, up 0.00% today and down 10.17% over the past 12 months. Shares have traded between $0.051 and $0.135 over the past 52 weeks. GLH trades on a price-to-earnings ratio of 44.83, above the Healthcare sector median of 14.96. In its most recent reported period (ending 31 Dec 2025), Global Health reported revenue of $3.6M and a net loss of $629,201.
About Global Health Limited
Headquartered in Melbourne, Australia, and established in 1985, Global Health Limited develops and supplies digital health solutions for the Australian healthcare sector. Their comprehensive suite of software addresses various needs, including specialized platforms for mental health practitioners like psychologists and psychiatrists. The company provides integrated solutions across community health and human services, encompassing areas such as drug and alcohol support, disability services, post-acute and community care, and rehabilitation. Furthermore, they offer solutions for home and aged care, general practice, pharmacies, and consumer engagement. Key products include the MasterCare Electronic Medical Record (EMR), MasterCare + for digitizing services, and MasterCare Patient Administration System (PAS). PrimaryClinic provides medical and practice management capabilities for GPs and specialists, enabling shared patient demographic data. Other significant tools are ReferralNet for secure document exchange, LifeCard as a personal health record, and HotHealth for digital patient engagement. Complementing these are the MasterCare Data Warehouse for streamlined data analysis, e-switch middleware for seamless system integration, a Patient Portal for digital pre-admission data capture, and Altitude, their cloud hosting service.
CEO
Alumootil Mathew Ravi Cherian
